뉴욕의 주요우울장애 임상 시험
주요우울장애 관련 연구 47개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- 외 1개
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Ima Clinical Research - Nyc Midtown, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07621237A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
- Davis Clinical (Adams Clinical Bronx), The Bronx
- 외 1개
피험자 모집 중3상
18세 ~ 85세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06793397Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- SPRI Clinical Trials, LLC, Brooklyn
- Manhattan Behavioral Medicine, New York
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
- Vanda Investigational Site, Staten Island
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06830044DBS for TRD With the Medtronic Percept PC
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
피험자 모집 중
25세 ~ 70세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT05773755Pattern Separation in Major Depressive Disorder
- New York State Psychiatric Institute (NYSPI), New York
피험자 모집 중1상
18세 ~ 50세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07139834A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Brooklyn
- Seaport Investigator Site, Cedarhurst
- Seaport Investigator Site, New York
- 외 1개
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Integrative Clinical Trials LLC, Brooklyn
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Bioscience Research, LLC, Mount Kisco
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, New York
- Draig Clinical Site, New York
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Mount Sinai Hospital, New York
피험자 모집 중
22세 ~ 70세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06423430A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- 외 3개
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07573176A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, New York
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06911112NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06963021A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Harlem, New York
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Harlem, New York
피험자 모집 중3상
18세 ~ 75세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Integrative Clinical Trials, Brooklyn
- Richmond Behavioral Associates, Staten Island
피험자 모집 중3상
18세 ~ 74세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc., Cedarhurst
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc, Cedarhurst
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
피험자 모집 중2상
18세 ~ 64세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glen Oaks
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, Mount Kisco
- Neurocrine Clinical Site, New York
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Brooklyn
- Clinical Research Site, New York
- Clinical Research Site, New York
- 외 2개
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 7. 24. 업데이트됨 · NCT07484217Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
- NYU Langone Health, New York
피험자 모집 중
24세 ~ 65세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07111390A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07276997tDCS: Sleep to Mood in Depression (S2M-D)
- NYU Langone Health, New York
피험자 모집 중
18세 ~ 65세 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT07572526Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Harlem, New York
- Adams Clinical, Bronx, The Bronx
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Medical Research Network, LLC, New York
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 5. 11. 업데이트됨 · NCT06524830Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
피험자 모집 중4상
60세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT05004987Maintenance rTMS for Depression (Maitr-De)
- Weill Cornell Medicine, New York
피험자 모집 중
18세 ~ 80세 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT06938841Neutralizing Interleukin (IL)-6
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중2상건강한 지원자 환영
18세 ~ 70세 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT07493317Mindfulness-Based fMRI Neurofeedback for Depression
- Columbia University Irving Medical Center, New York
피험자 모집 중
13세 ~ 18세 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT05617495Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
- Weill Cornell Medicine, New York
피험자 모집 중
50세 ~ 80세 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT05925322Biomarker-guided rTMS for Treatment Resistant Depression
- Weill Cornell Medicine, New York
피험자 모집 중3상
22세 ~ 65세 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT04041479The Role of mGluR5 in CBT-I
- Stony Brook University: Dept of Psychiatry, Stony Brook
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 2. 17. 업데이트됨 · NCT07076342Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- NYU Langone Health, New York
- Nathan Kline Institute for Psychiatric Research, Orangeburg
피험자 모집 중
18세 ~ 65세 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #105, Brooklyn
- Autobahn Site #134, Brooklyn
- Autobahn Site #104, Staten Island
피험자 모집 중2상
18세 ~ 65세 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mount Kisco
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 10. 29. 업데이트됨 · NCT06786624Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
- James J. Peters Veterans Affairs Medical Center, The Bronx
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2025. 9. 25. 업데이트됨 · NCT06854224ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.